DMCX ApS: Financial statements 2023
CVR: 36441127
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
DMCX ApS (CVR 36441127) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -156,411 and a net result of DKK -179,291 compared with DKK -223,683 the year before. Equity in the 2023 report amounted to DKK -190,907.
- Gross Profit
- DKK -156,411
- Profit/Loss
- DKK -179,291
- Equity
- DKK -190,907
- Total Assets
- DKK 125,474
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -156 t. | -179 t. | -191 t. | 0 |
| 2022 | - | -67 t. | -224 t. | -11 t. | 0 |
| 2021 | - | 1 mio. | 649 t. | 252 t. | 0 |
| 2020 | - | -45 t. | -37 t. | -208 t. | 0 |
| 2019 | - | -60 t. | -74 t. | -171 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DMCX ApS has published its annual report for 2022. Gross profit came to DKK -67,405, and the net result was DKK -223,683.
About DMCX ApS
DMCX ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of David Jørgensen Manniche. The company is owned by David Jørgensen Manniche. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -8,114 and a net result of DKK -7,133 compared with DKK -27,659 the year before. Equity in the 2025 report amounted to DKK -225,699.